Brief: ChemoCentryx Says EMA Committee Gives Positive Recommendation For Use Of Tavneos In ANCA Vasculitis
Nov 12 (Reuters) - ChemoCentryx Inc CCXI.O :
* CHEMOCENTRYX - POSITIVE RECOMMENDATION FOR USE OF TAVNEOS
IN
ANCA VASCULITIS ADOPTED BY EMA'S COMMITTEE FOR MEDICINAL
PRODUCTS FOR HUMAN USE
Source text for Eikon: ID:nGNX3jCj77
Further company coverage: CCXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Churchill Capital XI
See all newsBrief: AGCO To Pilot Digit Humanoid Robot At Hesston, Kansas Facility In 2027
Brief: Agility Robotics Announces Audit Committee Chair For Planned Public-Company Board
Brief: Agility Robotics And Churchill Capital Corp Xi S-4 Registration Statement Declared Effective By SEC In Connection With Proposed Business Combination
Brief: Agility And Fort Robotics Announce Strategic Partnership To Advance Humanoid Robot Safety
Deals of the day-Mergers and acquisitions